Ideas – Page 282

June 26, 2018

Published by admin_auro at June 26, 2018

Categories

Hypertonic saline-based adjunct therapy for cardiac hypertrophy and fibrosis: Hypertonic saline decreases MiR-29 expression, activates wnt- signaling and its components GSK3B, ICAT/CTNNBIP1, HBP1 and GLIS2, attenuates pathologic hypertrophy, inhibits fibrosis of the heart tissue, and improves cardiac function via up regulation of its target gene, 26/June/2017, 10.27 pm

Introduction: What they say: A recent study from the Institute of Pharmacology and Toxicology, Technical University Munich (TUM), 80802, Munich, Germany; DZHK (German Center for Cardiovascular […]

June 26, 2018

Published by admin_auro at June 26, 2018

Categories

Bacillus Calmette Guerin (BCG) vaccine-based therapy for body weight control, energy homeostasis, and TIIDM: BCG vaccine decreases CADM1 and its downstream target genes that inhibit glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 26/June/2017, 11.26 am

Introduction: What they say A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]

June 24, 2018

Published by admin_auro at June 24, 2018

Categories

A salty way to keep the cardiac diseases at bay-hard to believe though(!): Hypertonic saline-based adjunctive Regenerative therapy for Cardiomyopathy: Hypertonic saline decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy, via up regulation of its target gene, 24/June/2018, 8.29 pm

Introduction: What they say A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart […]

June 24, 2018

Published by admin_auro at June 24, 2018

Categories

Awakening the sleeping/cancer-protecting angels in mutant p53-expressing human tumors: Sitagliptin (trade name: Januvia), a DPP4 inhibitor, increases the expression of tumor suppressors genes, such as RECK, CADM1, TA-p73, TAp63, p53, and others, induces regression of p53-mutated human tumors, via down regulation of its target gene, 24/June/2018, 8.19 pm

From Significance of the study to Public health relevance: Given that: (1) cancer suppressor p53 is mutated in more than 50% of human cancers of different […]